- |||||||||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk, Choriomon (human choriomon gonadotropin (hCG)) / IBSA Institute Biochemical SA
Enrollment open: KLIN-HEALTH: Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome (clinicaltrials.gov) - Apr 24, 2023 P3, N=120, Recruiting, Unknown status --> Completed | N=100 --> 300 | Trial completion date: May 2020 --> Jan 2023 | Trial primary completion date: Apr 2020 --> Jan 2023 Not yet recruiting --> Recruiting
- |||||||||| Ovidrel (choriogonadotropin alfa) / EMD Serono, Choriomon (human choriomon gonadotropin (hCG)) / IBSA Institute Biochemical SA
CAN THE DUAL TRIGGER PROTOCOL IMPACT EMBRYO PLOIDIA? (Anaheim Convention Center - Poster Hall in Expo Hall) - Aug 21, 2022 - Abstract #ASRM2022ASRM_1125; IMPACT STATEMENT: The results of this study may assist in the selection of patients who may benefit from the dual trigger protocol. In addition, the study will contribute to the development of new studies to better understand the processes of ovulation induction and its effect on embryonic aneuploidies.
- |||||||||| Choriomon (human choriomon gonadotropin (hCG)) / IBSA Institute Biochemical SA
Trial completion: Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders (clinicaltrials.gov) - Jul 23, 2021 P3, N=140, Completed, Not yet recruiting --> Completed | Trial completion date: Dec 2021 --> Sep 2021 | Trial primary completion date: Sep 2021 --> Mar 2021 Recruiting --> Completed
- |||||||||| Ovidrel (choriogonadotropin alfa) / EMD Serono, NN1213 / Novo Nordisk, Choriomon (human choriomon gonadotropin (hCG)) / IBSA Institute Biochemical SA
Trial completion: Triggering of Follicular Maturation (clinicaltrials.gov) - Mar 20, 2019 P3, N=160, Completed, Recruiting --> Completed | Trial primary completion date: May 2019 --> Aug 2019 Recruiting --> Completed
- |||||||||| clomifene citrate / Generic mfg.
Trial completion date, Trial primary completion date: Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS (clinicaltrials.gov) - Oct 26, 2018 P4, N=100, Recruiting, Trial completion date: Dec 2017 --> Dec 2019 | Trial primary completion date: Nov 2017 --> Nov 2019 Trial completion date: Sep 2017 --> Sep 2019 | Trial primary completion date: Aug 2017 --> Aug 2019
- |||||||||| Ovidrel (choriogonadotropin alfa) / EMD Serono, Choriomon (human choriomon gonadotropin (hCG)) / IBSA Institute Biochemical SA
Enrollment open: Triggering of Follicular Maturation (clinicaltrials.gov) - Nov 14, 2017 P3, N=148, Recruiting, Trial primary completion date: Jun 2017 --> Jun 2018 Not yet recruiting --> Recruiting
- |||||||||| Ovidrel (choriogonadotropin alfa) / EMD Serono, Choriomon (human choriomon gonadotropin (hCG)) / IBSA Institute Biochemical SA
New P3 trial: Triggering of Follicular Maturation (clinicaltrials.gov) - Sep 27, 2016 P3, N=148, Not yet recruiting,
- |||||||||| metformin / Generic mfg.
Phase classification, Trial primary completion date: Metformin for the Treatment of Unexplained Oligozspermia (clinicaltrials.gov) - Aug 12, 2015 P4, N=600, Recruiting, Trial primary completion date: Jun 2016 --> Jun 2017 Phase classification: P=N/A --> P4 | Trial primary completion date: Dec 2014 --> Sep 2016
|